Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Drug repurposing stories

Sep 20, 2026

Alpha-lipoic acid shows early promise for progressive MS in first positive neurological MAMS trial

A multi-arm, multi-stage trial has reported positive results for alpha-lipoic acid in treating progressive multiple sclerosis, marking the first time this innovative trial design has succeeded in a neurological condition. Diabetes drug metformin was removed from the trial, though the design allows additional drugs to be tested.

Sep 20, 2026·1 source
00
Jun 3, 2026

GLP-1 Drugs Show Beneficial Effects Across Multiple Cancer Types, New Research Suggests

Research indicates that GLP-1 drugs may have beneficial effects across many types of cancer, expanding the potential therapeutic applications of this drug class beyond diabetes and obesity.

Jun 3, 2026·1 source
00
Apr 18, 2026

Blood Pressure Drug Shows Effectiveness Against Antibiotic-Resistant Bacteria

Research published in Nature Communications reveals that a common blood pressure medication can effectively treat infections from antibiotic-resistant bacteria, offering a potential new weapon against drug-resistant infections responsible for over 35,000 U.S. deaths annually.

Apr 18, 2026·1 source
00

Top claims

  • ▪Existing treatments for relapsing multiple sclerosis target the immune system but do not stop the gradual nerve damage that leads to long-term disability in progressive multiple sclerosis.
  • ▪The Octopus clinical trial is funded by public donations and the MS Society's Stop MS Appeal.
  • ▪Participants in the metformin arm of the Octopus clinical trial will leave the trial and stop taking the drug in the coming weeks.

Subtopics

Drug Approval and Clinical Trials3Clinical trial design1GLP-1 drugs1GLP-1 medications1Lifestyle, Wellness and Nutrition1Medical research1Obesity treatment1Public health1Secure communications1

Related timelines

Congress

108 stories

Crypto hacks

100 stories

Trump administration

116 stories

US midterm elections

100 stories

AI Data Center Gold Rush

101 stories